Canopy Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$310K Sell
3,381
-110
-3% -$9.62K 0.09% 176
2026
Q1
$298K Buy
3,491
+949
+37% +$84.6K 0.1% 169
2025
Q4
$201K Buy
+2,542
New +$199K 0.07% 230
2025
Q3
Sell
-2,826
Closed -$257K 239
2025
Q2
$257K Buy
2,826
+59
+2% +$5.39K 0.09% 170
2025
Q1
$259K Sell
2,767
-122
-4% -$10.9K 0.1% 162
2024
Q4
$263K Buy
2,889
+22
+0.8% +$2.1K 0.1% 153
2024
Q3
$298K Buy
2,867
+9
+0.3% +$917 0.13% 139
2024
Q2
$277K Buy
2,858
+310
+12% +$28.6K 0.13% 140
2024
Q1
$229K Buy
+2,548
New +$216K 0.11% 158

Other funds holding CL

Canopy Partners's CL Position: Q2 2026 in Review

Canopy Partners reduced its Colgate-Palmolive (CL) stake by 3.2% in Q2 2026, selling an estimated $9.62K and leaving 3,381 shares worth $310K. The position accounts for 0.09% of the portfolio, ranked #176.

Canopy Partners first reported a position in CL in Q1 2024 and has held it in 9 quarters since. 586 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Canopy Partners held 3,381 shares of Colgate-Palmolive worth $310K as of Q2 2026.
  • Canopy Partners sold 110 Colgate-Palmolive shares in Q2 2026, an estimated $9.62K.
  • Colgate-Palmolive made up 0.09% of Canopy Partners's portfolio in Q2 2026, its #176 holding.
  • Canopy Partners first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 9 quarters since.
  • 586 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Canopy Partners's 13F filing for Q2 2026, filed 22 Jul 2026.